Prelude Therapeutics INC (PRLD) SEC Filings — 2024
17 SEC filings for Prelude Therapeutics INC (PRLD) in 2024.
Filings
- Prelude Therapeutics Files 8-K — 8-K · Dec 11, 2024
- Prelude Therapeutics Files Q3 2024 10-Q — 10-Q · Nov 6, 2024
- Prelude Therapeutics INC 8-K Filing — 8-K · Oct 24, 2024
- Prelude Therapeutics Files 8-K Report — 8-K · Sep 13, 2024
- Prelude Therapeutics Files 8-K Report — 8-K · Sep 9, 2024
- Prelude Therapeutics Files Q2 2024 10-Q — 10-Q · Aug 12, 2024
- Prelude Therapeutics Files 8-K on Shareholder Vote Matters — 8-K · Jun 18, 2024
- Prelude Therapeutics Files 8-K — 8-K · Jun 12, 2024
- Prelude Therapeutics Files 8-K/A Amendment — 8-K/A · May 16, 2024
- Prelude Therapeutics Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 7, 2024
- Prelude Therapeutics Inc. Announces 2024 Annual Meeting of Stockholders — DEF 14A · Apr 26, 2024
- Prelude Therapeutics Appoints New Chief Medical Officer — 8-K · Apr 10, 2024
- Prelude Therapeutics Inc. Files 2023 Annual Report on Form 10-K — 10-K · Feb 15, 2024
- Prelude Therapeutics INC SC 13G/A Filing — SC 13G/A · Feb 13, 2024
- Prelude Therapeutics: Dr. Krishna Vaddi Holds 10% Stake — SC 13G/A · Feb 12, 2024
- Deerfield Mgmt Discloses 4.13M Shared Vote in Prelude Therapeutics — SC 13G/A · Feb 12, 2024
- FMR LLC Cuts Prelude Therapeutics Stake to 0.630% — SC 13G/A · Jan 10, 2024